Limited Cutaneous Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Limited Cutaneous Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Patients Diagnosed With Scleroderma: Physical Performance and Functionality
Clinical trial update for NCT07183072 indicating ongoing recruitment at Hacettepe University to assess physical performance and functionalit…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis [NA]
A clinical trial update examining pathogenic mechanisms involved in the initiation and progression of systemic sclerosis. It is currently no…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Exercise With Scleroderma Functional Outcomes [NA]
A completed clinical trial evaluating the effects of an exercise program on functional outcomes in patients with systemic sclerosis (sclerod…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) [Phase 2]
Phase 2 clinical trial update for mycophenolate in limited cutaneous systemic sclerosis (MINIMISE-Pilot).
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet [NA]
The trial evaluated the efficacy of ambrisentan in improving blood flow to the hands or feet in patients with limited cutaneous systemic scl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of Silicone-Associated Connective Tissue Diseases
The NIAMS-sponsored study on silicone-associated connective tissue diseases has completed, focusing on systemic sclerosis and limited cutane…